Literature DB >> 12752412

Lhermitte's sign following oxaliplatin-containing chemotherapy in a cisplatin-pretreated ovarian cancer patient.

G Ciucci, U De Giorgi, M Leoni, G Bianchedi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12752412     DOI： 10.1046/j.1468-1331.2003.00579.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN： 1351-5101            Impact factor:   6.089


× No keyword cloud information.
  3 in total

1.  Lhermitte sign after chemo-IMRT of head-and-neck cancer: incidence, doses, and potential mechanisms.

Authors:  Daniel Pak; Karen Vineberg; Felix Feng; Randall K Ten Haken; Avraham Eisbruch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-01-26       Impact factor: 7.038

2.  'Out of blue' Lhermitte's sign: three cases due to low cumulative doses of oxaliplatin.

Authors:  J M Jurado; B Pajares; D Olmos; I Sevilla; E Alba
Journal:  Ann Oncol       Date:  2008-10-31       Impact factor: 32.976

3.  Lhermitte's Sign following VMAT-Based Head and Neck Radiation-Insights into Mechanism.

Authors:  Huaising C Ko; Allison R Powers; Ren-dih Sheu; Sarah L Kerns; Barry S Rosenstein; Stephen C Krieger; Waleed F Mourad; Kenneth S Hu; Vishal Gupta; Richard L Bakst
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.